证券代码：688393 证券简称：安必平 公告编号：2025-049 广州安必平医药科技股份有限公司 股东减持股份计划公告 本公司董事会、全体董事及相关股东保证本公告内容不存在任何虚假记载、 误导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律 责任。 重要内容提示： 股东及董监高持有的基本情况 截至本公告披露日，股东诸暨高特佳睿安投资合伙企业（有限合伙）（以下 简称"诸暨高特佳"）及其一致行动人重庆高特佳睿安股权投资基金合伙企业（有 限合伙）（以下简称"重庆高特佳"）、杭州高特佳睿海投资合伙企业（有限合伙） （以下简称"杭州高特佳"）、杭州睿泓投资合伙企业（有限合伙）（以下简称"杭 州睿泓"）、董事王海蛟先生合计持有广州安必平医药科技股份有限公司（以下简 称"公司"或"安必平"）6,292,662 股，占公司总股本 6.7253%,上述股份来源 均为公司首次公开发行前股份，且已于 2021 年 8 月 20 日解除限售后上市流通 减持计划的主要内容 公司于近日收到股东诸暨高特佳、重庆高特佳、杭州高特佳、杭州睿泓出具 的《股份减持计划告知函》，上述主体拟通过集中竞价方式减持所持有的公司股 份 ...

Core Viewpoint - The company announced that certain shareholders plan to reduce their holdings through a centralized bidding process, which may impact the stock price and investor sentiment [1] Group 1: Shareholder Actions - Shareholders Zhuzhou Gaotejia, Chongqing Gaotejia, Hangzhou Gaotejia, and Hangzhou Ruihong intend to reduce their holdings by no more than 935,700 shares, representing up to 1% of the company's total share capital [1] - The reduction period is set to begin 15 trading days after the announcement and will last for three months [1]

Group 1 - The core point of the article is that Anbiping (SH 688393) announced a share reduction plan by its major shareholders, which may impact the stock price and market perception of the company [1] - As of the announcement date, shareholders including Zhuhai Gaotejia Ruian Investment Partnership and others hold approximately 6.73% of Anbiping's total shares, amounting to about 6.29 million shares [1] - The shareholders plan to reduce their holdings by up to approximately 940,000 shares, which is not more than 1% of the company's total share capital, within three months starting 15 trading days after the announcement [1] Group 2 - Anbiping's revenue composition for the year 2024 is projected to be 98.73% from in vitro diagnostics and 1.27% from other businesses [1] - The current market capitalization of Anbiping is reported to be 2.4 billion yuan [2]

Core Viewpoint - The company Anbiping (688393.SH) has announced that certain shareholders plan to reduce their holdings through a centralized bidding process, which may impact the stock's performance in the market [1] Group 1: Shareholder Actions - Shareholders Zhuzhou Gaotejia, Chongqing Gaotejia, Hangzhou Gaotejia, and Hangzhou Ruihong intend to reduce their holdings by no more than 935,700 shares, which represents up to 1% of the company's total share capital [1] - The reduction period is set to begin 15 trading days after the announcement and will last for three months [1]

Core Viewpoint - The company Anbiping (688393) announced that shareholders Zhuzhou Gaotejia and its concerted parties plan to reduce their holdings through centralized bidding, affecting up to 935,700 shares, which represents 1% of the company's total share capital [1] Group 1 - Shareholders involved in the reduction include Zhuzhou Gaotejia, Chongqing Gaotejia, Hangzhou Gaotejia, and Hangzhou Ruihong [1] - The planned reduction of shares is set to occur through a centralized bidding method [1] - The total number of shares to be reduced is capped at 935,700 [1]

Core Viewpoint - The company Anbiping (688393.SH) has received a share reduction plan notification from its shareholders, indicating a potential decrease in shareholding [1] Group 1 - The shareholders, including Zhuji Gaotejia, Chongqing Gaotejia, Hangzhou Gaotejia, and Hangzhou Ruihong, plan to reduce their holdings by up to 935,700 shares, which represents no more than 1.00% of the company's total share capital [1] - The reduction will be executed through centralized bidding and is set to take place within three months after a 15 trading day period following the announcement [1]

Core Viewpoint - The Ministry of Industry and Information Technology of China has announced the list of 129 companies that meet the current standards for the photovoltaic manufacturing industry, as per the regulations established in 2024 [1][2]. Group 1: Announcement Details - The announcement is identified as the 31st notice of 2025, published on October 29, 2025 [1][2]. - The list includes companies that have undergone a thorough evaluation process, including self-assessment reports, local reviews, expert evaluations, on-site verifications, local rechecks, and online public notices [2]. Group 2: Company Listings - The list comprises companies from various provinces, including: - Anhui: Tongwei Solar (Hefei) Co., Ltd. (modules), Hefei Zhongnan Optoelectronics Co., Ltd. (modules), and others [3][4]. - Guangdong: Dongguan Nanfang Glass Photovoltaic Technology Co., Ltd. (modules), Guangdong Aisuo Technology Co., Ltd. (batteries), and others [3][4]. - Jiangsu: Suzhou GCL-Poly Energy Technology Co., Ltd. (silicon wafers), and many others [4][5]. - Zhejiang: Zhejiang Jinko Solar Co., Ltd. (modules), and others [8][9]. Group 3: Company Changes - The announcement also includes changes in company names and types, such as: - Anhui Huasheng New Energy Technology Co., Ltd. changed to Anhui Huasheng New Energy Technology Co., Ltd. (modules) [10]. - Xi'an Longi Silicon Materials Co., Ltd. changed to Longi Green Energy Technology Co., Ltd. (silicon wafers) [10]. - Zhejiang Hongxi Photovoltaic Technology Co., Ltd. changed to Zhejiang Hongxi Energy Co., Ltd. (batteries) [10].

Core Insights - The medical device sector experienced a rise of 1.13% on October 31, with Caina Co., Ltd. leading the gains [1] - The Shanghai Composite Index closed at 3954.79, down 0.81%, while the Shenzhen Component Index closed at 13378.21, down 1.14% [1] Medical Device Sector Performance - Caina Co., Ltd. (301122) saw a closing price of 30.38, with a significant increase of 19.98% and a trading volume of 91,000 shares, amounting to a transaction value of 259 million [1] - Spring Medical (688236) closed at 28.88, up 14.47%, with a trading volume of 84,200 shares and a transaction value of 235 million [1] - ZhenDe Medical (603301) closed at 95.00, increasing by 9.07% with a trading volume of 211,900 shares, resulting in a transaction value of 1.951 billion [1] - Other notable performers included TuoJing Life (300642) with an 8.81% increase, and Rejing Bio (688068) with an 8.70% increase [1] Capital Flow Analysis - The medical device sector saw a net inflow of 475 million from institutional investors, while retail investors experienced a net outflow of 108 million [2][3] - Major stocks like Mindray Medical (300760) had a net inflow of 262 million from institutional investors, but a net outflow of 1.27 billion from retail investors [3] - Other stocks such as Furuishi (300049) and Lepu Medical (300003) also showed significant net inflows from institutional investors, indicating strong institutional interest [3]

广州安必平医药科技股份有限公司 2025 年第二次临时股东大会会议资料 会议资料 2025 年 11 月 广州安必平医药科技股份有限公司 2025 年第二次临时股东大会会议资料 公司代码：688393 公司简称：安必平 广州安必平医药科技股份有限公司 2025 年第二次临时股东大会 目录 | 2025 | 年第二次临时股东大会会议须知 | 2 | | --- | --- | --- | | 2025 | 年第二次临时股东大会会议议程 | 4 | | 2025 | 年第二次临时股东大会会议议案 | 6 | | | 议案一 关于撤销监事会暨废止《监事会议事规则》的议案 | 6 | | | 议案二 关于修订《公司章程》并办理工商变更登记的议案 | 7 | | | 议案三 关于修订《股东大会议事规则》等内部治理制度，制定《董事、高 | | | | 级管理人员薪酬管理制度》的议案 8 | | 1 广州安必平医药科技股份有限公司 2025 年第二次临时股东大会会议资料 2025 年第二次临时股东大会会议须知 为了维护全体股东的合法权益，确保股东大会的正常秩序和议事效率，保证 大会的顺利进行，根据《中华人民共和国公司法》《 ...

Core Insights - The internet healthcare sector experienced a slight increase of 0.21% on October 29, with notable gains from companies like Jiangyu Pingmin, which rose by 6.29% [1] - The Shanghai Composite Index closed at 4016.33, up 0.7%, while the Shenzhen Component Index closed at 13691.38, up 1.95% [1] Company Performance - Jiangyu Pingmin (301017) closed at 11.99 with a gain of 6.29%, trading volume of 201,100 shares and a transaction value of 242 million [1] - Furuishi (300049) closed at 74.48, up 6.20%, with a trading volume of 150,500 shares and a transaction value of 1.104 billion [1] - Xingqi Eye Medicine (300573) closed at 82.01, increasing by 5.29%, with a trading volume of 309,400 shares and a transaction value of 2.518 billion [1] - Other notable performers include Maidi Technology (603990) with a 2.98% increase and a transaction value of 384 million, and Hanhui Technology (300007) with a 2.68% increase and a transaction value of 1.402 billion [1] Market Dynamics - The internet healthcare sector saw a net outflow of 1.125 billion from institutional investors, while retail investors contributed a net inflow of 926 million [2][3] - The overall market sentiment indicated a mixed response, with some stocks experiencing significant declines, such as Jiayuan Technology (301117) which fell by 13.29% [2] - The trading activity highlighted a divergence in investor behavior, with institutional investors pulling back while retail investors remained active [2][3]